nitroglycerin and kynurenine

nitroglycerin has been researched along with kynurenine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Curzon, G; Green, AR1
Chadaide, Z; Fenyo, R; Knyihár-Csillik, E; Krisztin-Péva, B; Mihály, A; Németh, H; Toldi, J; Vécsei, L1
Chadaide, Z; Fenyo, R; Knyihár-Csillik, E; Krisztin-Péva, B; Németh, H; Toldi, J; Vécsei, L1
Bohár, Z; Fülöp, F; Párdutz, A; Tajti, J; Toldi, J; Vámos, E; Varga, H; Vécsei, L1
Fejes, A; Fülöp, F; Koch, J; Párdutz, A; Tajti, J; Toldi, J; Vámos, E; Vécsei, L1

Other Studies

5 other study(ies) available for nitroglycerin and kynurenine

ArticleYear
The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism.
    Biochemical pharmacology, 1970, Volume: 19, Issue:6

    Topics: Alanine; Allopurinol; Amino Acids; Animals; Brain; Brain Chemistry; Carbon Isotopes; Carboxy-Lyases; Histamine; Kynurenic Acid; Kynurenine; Male; Methanol; Methyldopa; Mixed Function Oxygenases; Niacinamide; Nicotinic Acids; Nitroglycerin; ortho-Aminobenzoates; Phenylalanine; Phenylbutyrates; Picolinic Acids; Pyridines; Pyridoxal Phosphate; Pyridoxine; Rats; Serotonin; Sulfuric Acids; Time Factors; Tryptophan; Tryptophan Oxygenase; Xanthurenates

1970
Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model.
    Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:4

    Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Genes, fos; Immunohistochemistry; Kynurenine; Male; Migraine Disorders; Neurons; Nitroglycerin; Probenecid; Rats; Rats, Wistar; Trigeminal Caudal Nucleus; Vasodilator Agents

2007
Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecid.
    Neuroscience letters, 2007, May-17, Volume: 418, Issue:2

    Topics: Adjuvants, Pharmaceutic; Afferent Pathways; Analgesics; Animals; Blood-Brain Barrier; Disease Models, Animal; Drug Synergism; Electric Stimulation; Immunohistochemistry; Kynurenine; Male; Migraine Disorders; Neurons, Afferent; Nitroglycerin; Nociceptors; Probenecid; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Synaptic Transmission; Treatment Outcome; Trigeminal Caudal Nucleus; Vasodilator Agents

2007
l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus.
    Neuropharmacology, 2009, Volume: 57, Issue:4

    Topics: Animals; Central Nervous System Agents; Cervical Vertebrae; Drug Synergism; Kynurenic Acid; Kynurenine; Male; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Nitroglycerin; Probenecid; Quinolones; Rats; Rats, Sprague-Dawley; Spinal Cord; Time Factors; Trigeminal Nuclei

2009
Kynurenate derivative attenuates the nitroglycerin-induced CamKIIα and CGRP expression changes.
    Headache, 2010, Volume: 50, Issue:5

    Topics: Animals; Calcitonin Gene-Related Peptide; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Gene Expression Regulation, Enzymologic; Isoenzymes; Kynurenic Acid; Kynurenine; Male; Nitroglycerin; Rats; Rats, Sprague-Dawley; Trigeminal Caudal Nucleus

2010